2025-01-10
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market. Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weight loss drugs, Ozempic and Wegovy. The company promises to offer less invasive pills, instead of injectables. Its most advanced product is an oral [...]
2025-01-03
Time to get into the habit of writing "2025" instead of 2024, and the year may have just begun, but the Engadget team is already working hard for CES 2025. This weekend, many from the Engadg [...]
2025-01-10
Tesla has quietly unveiled its facelifted Model Y with new styling that will help it keep up with rivals like Kia and Volvo. Though currently only available in the Asia Pacific region, the refreshed & [...]
2025-01-20
I am the first to admit that I am quite clumsy, so I always buy extra care protection for my devices. However, I'm still always shocked by the price of fixing whatever inevitable water damage or [...]